Related Experiment Video

Updated: May 31, 2026

Isolation of Whole Cell Protein Lysates from Mouse Facial Processes and Cultured Palatal Mesenchyme Cells for Phosphoprotein Analysis
07:26

Isolation of Whole Cell Protein Lysates from Mouse Facial Processes and Cultured Palatal Mesenchyme Cells for Phosphoprotein Analysis

Published on: April 1, 2022

Involvement of PRIP, phospholipase C-related, but catalytically inactive protein, in bone formation

Koshiro Tsutsumi1, Miho Matsuda2, Miho Kotani3

  • 1Laboratory of Molecular and Cellular Biochemistry, Kyushu University, Fukuoka 812-8582, Japan; Division of Fixed Prosthodontics, Kyushu University, Fukuoka 812-8582, Japan.

The Journal of Biological Chemistry
|July 16, 2011
PubMed

Insights

Phospholipase C-related, but catalytically inactive protein (PRIP) negatively regulates bone formation. PRIP-deficient mice exhibit enhanced bone mass due to increased bone formation and osteoblast differentiation.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Bone Biology

Background:

  • PRIP (phospholipase C-related, but catalytically inactive protein) is a novel protein.
  • PRIP deficiency in mice leads to hormonal imbalances resembling osteoporosis causes.
  • This study investigates PRIP's role in bone properties.

Purpose of the Study:

  • To analyze the bone properties of PRIP-deficient mice.
  • To determine the effect of PRIP on bone formation and osteoblast differentiation.
  • To elucidate the molecular mechanisms underlying PRIP's role in bone metabolism.

Main Methods:

  • Three-dimensional analysis of femur bone mineral density and trabecular bone volume.
  • Histomorphometrical assay of bone formation parameters (e.g., bone formation rate, osteoblast number).
  • In vitro culture of primary calvarial cells to assess osteoblast differentiation and gene expression.
  • Analysis of Smad1/5/8 phosphorylation in response to bone morphogenetic protein.

Main Results:

  • PRIP-deficient mice showed increased bone mineral density and trabecular bone volume.
  • Bone formation parameters, including osteoblast number and activity, were significantly upregulated in PRIP-deficient mice.
  • Osteoblast differentiation was enhanced in PRIP-deficient mice, evidenced by increased alkaline phosphatase activity and marker gene expression.
  • PRIP-deficient cells exhibited prolonged Smad1/5/8 phosphorylation upon BMP stimulation.

Conclusions:

  • PRIP plays a crucial role in the negative regulation of bone formation.
  • PRIP deficiency leads to increased bone mass by enhancing bone formation and osteoblast differentiation.
  • These findings suggest PRIP as a potential therapeutic target for bone diseases like osteoporosis.

More Related Videos

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...